Literature DB >> 18728638

Whole animal in vivo imaging after transient, nonviral gene delivery to the rat central nervous system.

Ellen S Hauck1, Shaomin Zou, Keith Scarfo, Michael H Nantz, James G Hecker.   

Abstract

We previously showed that a vector:lipid delivery system, comprised of a plasmid DNA vector and cationic lipid (lipoplex), when injected into the cerebrospinal fluid (CSF) of rats can deliver reporter genes in vivo efficiently and with widespread expression to the Central Nervous System (CNS). To further characterize this delivery system, we now present experiments that demonstrate the in vivo time-to-peak expression of the reporter gene, firefly luciferase. We infused a formulated lipoplex containing the lipid MLRI [dissymmetric myristoyl (14:0) and lauroyl (12:1) rosenthal inhibitor-substituted compound formed from the tetraalkylammonium glycerol-based DORI] and pNDluc, a luciferase vector, into CSF in the cisterna magna (CM) of the rat. Luciferase activity was followed over time by bioluminescence imaging after injection of luciferin. Our results show that luciferase activity in the CNS of rats is widespread, peaks 72 hours after injection into CM and can be detected in vivo for at least 7-10 days after peak expression. We further show that in contrast to injection into CSF, enzyme activity is not widely distributed after injection of the vector into brain parenchyma, emphasizing the importance of CSF delivery to achieve widespread vector distribution. Finally, we confirm the distribution of firefly luciferase in brain by immunohistochemical staining from an animal that was euthanized at the peak of enzyme expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728638      PMCID: PMC2575133          DOI: 10.1038/mt.2008.183

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  23 in total

1.  Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system.

Authors:  J G Hecker; L L Hall; V R Irion
Journal:  Mol Ther       Date:  2001-03       Impact factor: 11.454

2.  Quantitative comparison of click beetle and firefly luciferases for in vivo bioluminescence imaging.

Authors:  Tewfik Miloud; Carmen Henrich; Günter J Hämmerling
Journal:  J Biomed Opt       Date:  2007 Sep-Oct       Impact factor: 3.170

3.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

4.  Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells.

Authors:  B S Chapman; R M Thayer; K A Vincent; N L Haigwood
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

5.  Cell uptake and tissue distribution of radioiodine labelled D-luciferin: implications for luciferase based gene imaging.

Authors:  K-H Lee; S S Byun; J-Y Paik; S Y Lee; S H Song; Y S Choe; B-T Kim
Journal:  Nucl Med Commun       Date:  2003-09       Impact factor: 1.690

6.  Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice.

Authors:  J S Burgos; M Rosol; R A Moats; V Khankaldyyan; D B Kohn; M D Nelson; W E Laug
Journal:  Biotechniques       Date:  2003-06       Impact factor: 1.993

7.  Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy.

Authors:  Alnawaz Rehemtulla; Daniel E Hall; Lauren D Stegman; Uttara Prasad; Grace Chen; Mahaveer Swaroop Bhojani; Thomas L Chenevert; Brian D Ross
Journal:  Mol Imaging       Date:  2002 Jan-Mar       Impact factor: 4.488

8.  Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system.

Authors:  Dua M Anderson; Leon L Hall; Anitha R Ayyalapu; Van R Irion; Michael H Nantz; James G Hecker
Journal:  Hum Gene Ther       Date:  2003-02-10       Impact factor: 5.695

9.  A versatile linker for nontoxic polyamine-mediated DNA transfection.

Authors:  Edmund J Niedzinski; Scott K Fujii; Mike E Lizarzaburu; James G Hecker; Michael H Nantz
Journal:  Mol Ther       Date:  2002-08       Impact factor: 11.454

10.  Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden.

Authors:  Zain Paroo; Robert A Bollinger; Dwaine A Braasch; Edmond Richer; David R Corey; Peter P Antich; Ralph P Mason
Journal:  Mol Imaging       Date:  2004-04       Impact factor: 4.488

View more
  10 in total

1.  A single intrathecal injection of DNA and an asymmetric cationic lipid as lipoplexes ameliorates experimental autoimmune encephalomyelitis.

Authors:  Srikanth Yellayi; Brendan Hilliard; Mustafa Ghazanfar; Akivaga Tsingalia; Michael H Nantz; Laura Bollinger; Fabian de Kok-Mercado; James G Hecker
Journal:  Mol Pharm       Date:  2011-07-19       Impact factor: 4.939

2.  Nucleophilic cationization reagents.

Authors:  Souvik Biswas; Xuan Huang; Wesley R Badger; Michael H Nantz
Journal:  Tetrahedron Lett       Date:  2010       Impact factor: 2.415

3.  DNA nanoparticles: detection of long-term transgene activity in brain using bioluminescence imaging.

Authors:  David M Yurek; Anita M Fletcher; Matthew McShane; Tomasz H Kowalczyk; Linas Padegimas; Marcy R Weatherspoon; Michael D Kaytor; Mark J Cooper; Assem G Ziady
Journal:  Mol Imaging       Date:  2011-04-27       Impact factor: 4.488

Review 4.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

5.  Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.

Authors:  S Zou; K Scarfo; M H Nantz; J G Hecker
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

6.  Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences.

Authors:  J Cutrera; D Dibra; X Xia; S Li
Journal:  Cancer Gene Ther       Date:  2009-08-28       Impact factor: 5.987

Review 7.  Intrathecal drug delivery in the era of nanomedicine.

Authors:  M J Fowler; J D Cotter; B E Knight; E M Sevick-Muraca; D I Sandberg; R W Sirianni
Journal:  Adv Drug Deliv Rev       Date:  2020-03-03       Impact factor: 15.470

Review 8.  Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System.

Authors:  James-Kevin Y Tan; Drew L Sellers; Binhan Pham; Suzie H Pun; Philip J Horner
Journal:  Front Mol Neurosci       Date:  2016-11-01       Impact factor: 5.639

9.  Locally induced neural stem cells/pluripotent stem cells for in vivo cell replacement therapy.

Authors:  Ti-Fei Yuan; Oscar Arias-Carrión
Journal:  Int Arch Med       Date:  2008-09-24

Review 10.  Non-Viral Delivery of RNA Gene Therapy to the Central Nervous System.

Authors:  Ellen S Hauck; James G Hecker
Journal:  Pharmaceutics       Date:  2022-01-11       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.